Dream engineering can help solve ‘puzzling’ questions
2026-02-05
EVANSTON, Ill. --- We’ve all heard the best approach to solve a problem is to “sleep on it.” It turns out there may be more truth to this adage than previously thought. While stories abound of eureka moments surfacing from dreams, scientific evidence has remained elusive, due to the challenge of systematically manipulating dreams.
A new study by neuroscientists at Northwestern University validates the possibility of influencing dreams and offers a crucial step to support the theory that dreams in REM sleep — the rapid ...
Sport: ‘Football fever’ peaks on match day
2026-02-05
The mean stress level of fans of the football club Arminia Bielefeld was 41% higher on the day of the German Football Association’s (DFB-Pokal) 2025 Cup final compared to non-match days, according to a study published in Scientific Reports. The authors suggest that this reaction, known as ‘football fever’, may be driven by the intensity of fans’ emotions towards their ...
Scientists describe a window into evolution before the tree of life
2026-02-05
All life on Earth shares a common ancestor that lived roughly four billion years ago. This so-called “last universal common ancestor” represents the most ancient organism that researchers can study.
Previous research on the last universal common ancestor has found that all the characteristics we see in organisms today, like having a cell membrane and a DNA genome, were already present by the time of this ancestor. So, if we want to understand how these foundational characteristics of life first emerged, then we need to be able to study evolutionary history prior to the last universal common ancestor.
In a new article ...
Survival of patients diagnosed with cancer during the COVID-19 pandemic
2026-02-05
About The Study: This cohort study found that individuals diagnosed with cancer in 2020 and 2021 experienced worse short-term survival than those diagnosed between 2015 and 2019, suggesting substantial harms associated with cancer care disruptions during the first 2 years of the COVID-19 pandemic.
Corresponding Author: To contact the corresponding author, Todd Burus, PhD, email tburus@uky.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2025.6332)
Editor’s Note: Please ...
Growth trajectories in infants from families with plant-based or omnivorous dietary patterns
2026-02-05
About The Study: In this cohort study, infants from vegan households had growth patterns similar to those from omnivorous households, with a higher odds of early underweight that decreased by age 24 months. In the context of developed countries, these findings seem reassuring. Further research should examine vegan diet quality and the impact of nutritional counseling during pregnancy and infancy in supporting optimal infant development.
Corresponding Author: To contact the corresponding author, Kerem Avital, MPH, email kerema@post.bgu.ac.il.
To access the embargoed study: Visit our For The Media website at this link ...
Korea University College of Medicine hosts lecture by Austrian neuropathology expert, Professor Adelheid Wöhrer
2026-02-05
Korea University College of Medicine recently hosted a special lecture by Professor Adelheid Wöhrer from the Institute of Neuropathology and Neuro-Molecular Pathology at the Medical University of Innsbruck, Austria.
The event was conducted as part of the Research Nexus Program, which seeks to expand global research networks and promote international collaboration. Under the theme Establishing a Model for the Development and Evolution of Refractory Gliomas through Korea–Austria Research Cooperation, researchers from both countries discussed strategies for joint research to better understand the complex developmental and evolutionary mechanisms of treatment-resistant ...
5-FU chemotherapy linked to rare brain toxicity in cancer patient
2026-02-05
“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.”
BUFFALO, NY — February 5, 2026 — A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Silent toxicity: A rare case of 5-fluorouracil-induced hyperammonemic encephalopathy.”
In this report, Areti Kalfoutzou from the National ...
JMIR Publications introduces the new Karma program: A merit-based reward system dedicated to peer review excellence
2026-02-05
(Toronto, February 5, 2026) JMIR Publications, a leader in open access scholarly publishing, today announced the launch of the new Karma Reviewer Rewards Program. This initiative introduces a specialized, merit-based framework designed to elevate and reward the critical role of peer reviewers in the scientific process.
The evolved Karma program marks a strategic shift toward a quality-focused reward model. Moving away from traditional volume-based incentives, the new system ensures that rewards ...
H5N1 causes die-off of Antarctic skuas, a seabird
2026-02-05
More than 50 skuas in Antarctica died from the high pathogenicity avian influenza virus H5N1 in the summers of 2023 and 2024, marking the first documented die-off of wildlife from the virus on the continent. That is confirmed for the first time in a study led by Erasmus MC in The Netherlands and the University of California, Davis. It published this week in the Nature journal Scientific Reports.
A relative of gulls, skuas are predatory, large brown birds living mostly in polar and subpolar environments. Similar ...
Study suggests protein made in the liver is a key factor in men’s bone health
2026-02-05
New research suggests the liver plays a previously unrecognized role in bone health, but only in males.
A McGill University-led study published in Matrix Biology found that a protein made in the liver helps regulate bone growth in male mice, but not in females. The findings may help explain why men with liver disease are more likely to experience bone loss.
The protein, known as plasma fibronectin, is naturally present in blood at higher levels in men than in women, declines when the liver is damaged and builds up in bone to modulate bone formation. This suggests men rely more heavily on the protein to maintain bone strength than do women.
“About ...
Last chance to get a hotel discount for the world’s largest physics meeting
2026-02-05
Next month, thousands of scientists from around the world will convene to share new research results from across physics at the American Physical Society’s Global Physics Summit. The conference will be held in Denver and online everywhere March 15-20.
Press registration
News media with valid APS press credentials may register for the meeting at no cost. To request press credentials, visit APS’ online newsroom. Registration will remain open throughout the meeting.
Housing information
Discounted hotel rates are available for in-person attendees at select hotels near the Colorado ...
Tooling up to diagnose ocean health
2026-02-05
Tooling up to diagnose ocean health
Field-deployable CRISPR-based biosensing platform could enable facile, real-time monitoring of marine barometer species and ecosystems
By Benjamin Boettner
(BOSTON) — Oceanic ecosystems are increasingly threatened by global warming which causes coral bleaching, species migration and, through the loss of habitats and biodiversity, food web disruptions on major scales. Also, pollutants such as plastics and other marine debris, wastewater, as well as chemical runoffs, including oil spills, cause major ecosystem disruptions. Importantly, given the interconnectedness of all life on the planet, the deteriorating health of our ...
Family Heart Foundation teams up with former NFL quarterback Matt Hasselbeck to launch “tackle cholesterol™: Get into the LDL Safe Zone®”
2026-02-05
FERNANDINA BEACH, Fla., February 3, 2026 — To kick off Super Bowl LX week and American Heart Month, the Family Heart Foundation, a leading research and advocacy organization, is teaming up with three-time Pro Bowler and former Seattle NFL quarterback Matt Hasselbeck to launch a national campaign focused on raising awareness of high cholesterol as a key risk factor for heart attack and stroke. The campaign, “Tackle Cholesterol: Get into the LDL Safe Zone,” reinforces the importance of early ...
New study shows Ugandan women reduced psychological distress and increased coping using Transcendental Meditation after COVID-19 lockdown
2026-02-05
A peer reviewed, randomized controlled study with 199 women living in poverty in the city slums of Uganda was published today in Health Care for Women International. This study was conducted following two extended country-wide lockdowns in Uganda during the Covid 19 pandemic. Researchers found that the Transcendental Meditation® (TM®) technique reduced perceived stress, anger, and fatigue; increased self-efficacy; and improved sleep quality. TM helped these women to improve their mental and physical health and positively impacted their ability to cope in this crisis.
“The Covid lockdowns in Uganda, which resulted in food shortages, lack of employment, ...
University of Maryland School of Medicine researchers discover that vaginal bacteria don’t always behave the same way
2026-02-05
For decades, gynecological tests have relied on a simplified view of the vaginal microbiome, categorizing bacteria as either “good” or “bad.” New research from University of Maryland School of Medicine scientists challenges that assumption, revealing that bacteria of the same species can behave in fundamentally different ways, with important implications for women’s health.
Today, gynecological tests largely focus on detecting two groups of bacteria in the vaginal microbiome: Lactobacillus, generally associated with health, and Gardnerella, which has been linked to Bacterial Vaginosis (BV), increased risk of sexually transmitted diseases, ...
New approach to HIV treatment offers hope to reduce daily drug needs
2026-02-05
CLEVELAND— More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS).
The drugs are effective but don’t eliminate the virus; HIV remains hidden in “reservoirs” throughout the body, ready to reactivate if treatment stops.
But researchers at Case Western Reserve University, in collaboration with the University of Pittsburgh, have made a significant breakthrough in HIV treatment. They’ve ...
New stem cell treatment may offer hope for Parkinson’s disease
2026-02-05
LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more than one million people in the United States, with approximately 90,000 new cases diagnosed each year. Although available treatments can help manage symptoms, there is currently no cure or therapy proven to slow the progression of the disease.
Parkinson’s disease is associated with reduced dopamine release in the brain. Dopamine is a neurotransmitter essential for movement, memory, mood and ...
Researchers find new way to slow memory loss in Alzheimer’s
2026-02-05
Alzheimer’s disease is often measured in statistics: millions affected worldwide, cases rising sharply, costs climbing into the trillions. For families, the disease is experienced far more intimately. “It’s a slow bereavement,” says Cold Spring Harbor Laboratory Professor Nicholas Tonks, whose mother lived with Alzheimer’s. “You lose the person piece by piece.”
There’s a lot of discussion about how the neurodegenerative disorder may be caused by a buildup of “plaque” ...
Insilico Medicine nominates ISM5059, the peripheral-restricted NLRP3 inhibitor as preclinical candidate
2026-02-05
NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source.
Unlike ISM8969, Insilico’s brain-penetrant NLRP3 pipeline already with FDA IND clearance, ISM5059 features a completely different chemical core designed for peripheral-restricted potency.
Empowered by AI, ISM5059 demonstrated robust efficacy, excellent safety profiles in preclinical ...
Low-temperature-activated deployment of smart 4D-printed vascular stents
2026-02-05
Cardiovascular diseases constitute a major global health concern. Various complications that affect normal blood flow in arteries and veins, such as stroke, blood clot formation in veins, blood vessel rupture, and coronary artery disease, often require vascular treatments. However, existing vascular stent devices often require complex, invasive deployment procedures, making it necessary to explore novel materials and manufacturing technologies that could enable such medical devices to work more naturally with the human body. Moreover, the development of ...
Clinical relevance of brain functional connectome uniqueness in major depressive disorder
2026-02-05
Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve diagnosis and treatment. Finding reliable neurobiological markers for MDD has been hampered by the methodological differences observed across neuroimaging studies. Traditional brain imaging studies have produced conflicting results, often due to differences in methods and analysis pipelines. This inconsistency has made it difficult to pinpoint reliable neurobiological signatures of depression.
Against this backdrop, a new study led by Research Fellow Siti Nurul Zhahara ...
For dementia patients, easy access to experts may help the most
2026-02-05
For Dementia Patients, Easy Access to Experts May Help the Most
Programs that match caregivers with patient navigators yield better outcomes than Alzheimer’sdrug – but combining the two may be best.
A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer’s medication, new research finds.
UC San Francisco researchers compared outcomes for patients in collaborative care programs with those taking lecanemab, one of two approved drugs that have been shown to slow progression of Alzheimer’s in some patients.
UCSF ...
YouTubers love wildlife, but commenters aren't calling for conservation action
2026-02-05
YouTube is a great place to find all sorts of wildlife content. It is not, however, a good place to find viewers encouraging each other to preserve that wildlife, according to new research led by the University of Michigan.
Out of nearly 25,000 comments posted to more than 1,750 wildlife YouTube videos, just 2% featured a call to action that would help conservation efforts, according to a new study published in the journal Communications Sustainability.
"Our results basically show that people like to watch videos of zoos and safaris and ...
New study: Immune cells linked to Epstein-Barr virus may play a role in MS
2026-02-05
Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans.
The study, published Feb. 5 in Nature Immunology, found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune ...
AI tool predicts brain age, cancer survival, and other disease signals from unlabeled brain MRIs
2026-02-05
Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, predicting dementia risk, detecting brain tumor mutations and predicting brain cancer survival. The tool. known as BrainIAC, outperformed other, more task-specific AI models and was especially efficient when limited training data were available. Results are published in Nature Neuroscience.
“BrainIAC has ...
Press-News.org - Free Press Release Distribution service.